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AbstrAct:
Invadopodia are extracellular matrix (ECM)-degrading protrusions formed by 
invasive cancer cells. Podosomes are structures functionally similar to invadopodia 
that  are  found  in  oncogene-transformed  fibroblasts  and  monocyte-derived  cells, 
including macrophages and osteoclasts. These structures are thought to play 
important roles in the pericellular remodeling of ECM during cancer invasion and 
metastasis. Much effort has been directed toward identification of the molecular 
components and regulators of invadopodia/podosomes, which could be therapeutic 
targets in the treatment of malignant cancers. However, it remains largely 
unknown how these components are assembled into invadopodia/podosomes and 
how the assembly process is spatially and temporally regulated. This review will 
summarize recent progress on the molecular mechanisms of invadopodia/podosome 
formation, with strong emphasis on the roles of lipid rafts and phosphoinositides.
IntroductIon
Metastatic dissemination of cancer cells is the leading 
cause of mortality in patients with malignant cancers 
[1, 2]. Cancer cells need to degrade the extracellular 
matrix (ECM), which exists in the basement membrane, 
tumor stroma, and blood vessel walls, to emigrate from 
original tumor sites and invade adjacent tissues, and to 
eventually form metastatic sites at distant organs [3]. 
These processes seem to be facilitated by the formation 
of invadopodia, which are ventral membrane protrusions 
with ECM degradation activity formed by invasive cancer 
cells [4-8] (Fig. 1A and B). The ability of cancer cells 
to form invadopodia is closely related to their invasive 
and metastatic properties [9-11]. Additionally, during 
intravasation, invadopodia-like protrusions in cancer 
cells were observed in vivo by intravital imaging [12]. 
Furthermore, a recent study showed that invadopodia 
perforate the native basement membrane, allowing the 
invasive cancer cells to invade into the stroma [13]. 
Oncogene-transformed fibroblasts and cells of monocyte 
lineage also form functionally similar structures called 
podosomes that have ECM degradation activity (Fig. 
1C and D). The podosomes of macrophages/osteoclasts 
are used not only to elicit their physiological functions, 
but also to help cancer cells achieve efficient metastasis. 
Therefore, invadopodia/podosomes and their molecular 
regulators are considered as potential targets in the 
development of therapeutic strategies for cancer invasion 
and metastasis. 
To date, many components of invadopodia have been 
reported, including proteins involved in the regulation of 
the actin cytoskeleton, cell signaling, cell-ECM adhesion, 
ECM degradation, and membrane remodeling [8, 14]. 
We and other researchers have previously proposed that 
invadopodia formation occurs in several steps [9, 13, 
15, 16]. Invadopodia precursors are assembled by actin 
polymerization machinery in response to extracellular 
stimuli. These structures are then stabilized by additional 
actin  polymerization,  and  finally  they  gather  matrix 
metalloproteinases to mature into functional invadopodia, 
which contain microtubules and intermediate filaments 
in addition to actin filaments. How these events occur 
at restricted sites on the plasma membrane of invasive Oncotarget 2010; 1:  320 - 328 321 www.impactjournals.com/oncotarget
cancer cells, however, is obscure. Recently, several studies 
regarding the role of membrane lipids in the regulation of 
invadopodia/podosome formation have been reported.
LIpId rAfts And cAveoLIn-1 In 
InvAdopodIA formAtIon
Lipid rafts are cholesterol- and sphingolipid-enriched 
membrane microdomains that are also referred to as lipid 
microdomains or detergent-resistant membranes (DRM). 
Lipid rafts have been implicated in a number of critical 
cellular processes, such as membrane transport and signal 
transduction [17, 18], as well as several pathological 
conditions, including cancer progression [19–21]. 
Caveolin-1 is a ubiquitously expressed scaffolding protein 
that is enriched in caveolae, which are subtypes of lipid 
rafts [22, 23]. Caveolin-1 is involved in several cellular 
functions such as endocytosis, vesicular transport, and 
signal transduction [23, 24]. 
Both we and Caldieri et al. recently reported that 
invadopodia are lipid raft-enriched domains in human 
breast cancer and melanoma cells [10, 25]. We also 
observed that lipid rafts were enriched at podosomes 
formed  by  Src-transformed  fibroblasts  (unpublished 
observations). The inhibition of lipid rafts by the depletion 
or sequestration of membrane cholesterol, or the blocking 
of glycosphingolipid synthesis, has been shown to impair 
invadopodia formation and function [10, 25]. Time-
lapse observation revealed that lipid raft membranes are 
actively trafficked and internalized around invadopodia, 
which indicates the possible involvement of lipid rafts in 
the transport of invadopodia components [10]. Several 
invadopodia components involved in actin polymerization 
and  membrane  trafficking,  including  neural  Wiskott-
Aldrich syndrome protein (N-WASP), dynamin-2, and 
Arf6, are known to localize at lipid rafts [17, 26, 27]. 
Therefore, lipid rafts may act as platforms for localizing 
and activating these molecular machineries at the sites of 
invadopodia formation, which results in focalized ECM 
degradation.
The 2 studies also revealed that caveolin-1 is 
an essential regulator of the invadopodia-mediated 
figure 1: Invadopodia and podosomes formed by different cell types. (A) Schematic diagram of invadopodia/podosomes (B) 
Invadopodia formation by MDA-MB-231 human invasive breast cancer cells. The cells were cultured on rhodamine-gelatin-coated coverslips 
and stained with phalloidin to detect invadopodia that are enriched with actin filaments (F-actin). Upper and lower panels are confocal images 
showing XY and XZ sections, respectively. Invadopodia were observed as dot-like structures containing F-actin, which degrade the rhodamine-
gelatin matrix, resulting in the loss of gelatin fluorescence in the region of the invadopodia (arrowheads). (C) Podosomes formed by NIH3T3 
cells transformed by constitutively active Src (NIH3T3 src). Parental NIH3T3 and NIH3T3 src cells were cultured and stained as described in 
(A). NIH3T3 src cells, but not parental NIH3T3 cells, form podosomes, which are observed as donut-like actin structures and colocalized with 
the gelatin degradation sites (arrowheads). (D) Podosome formation of macrophages and osteoclasts. RAW264.7 cells were cultured in the 
presence of lipopolysaccharide (LPS) (100 ng/ml) or RANKL (10 ng/ml) for 72 h to induce differentiation into the macrophages or osteoclasts, 
respectively. Cells were stained with phalloidin and 4’,6-diamidino-2-phenylindole (DAPI). Macrophages form podosomes that often organize 
into large clusters associated with the gelatin degradation sites (arrowheads). Osteoclasts form a dense circumferential band of F-actin, called 
the sealing zone (yellow arrowheads), and clusters of podosomes that are observed inside the sealing zone (white arrowheads). A large gelatin 
degradation region was observed under these structures.Oncotarget 2010; 1:  320 - 328 322 www.impactjournals.com/oncotarget
degradation of ECM, which indicates that caveolin-1 
plays an essential role in cancer cell invasion [10, 25]. 
Indeed, at least in breast cancer cell lines, caveolin-1 
expression is predominantly observed in invasive cell 
lines and well correlated with invadopodia activity 
[10]. In melanoma cells, caveolin-1 functions at 
invadopodia through cholesterol transport to maintain 
proper levels of plasma membrane cholesterol [25]. 
Meanwhile, caveolin-1 is primarily involved in the 
transport of lipid raft-associated membrane type I matrix 
metalloproteinase (MT1-MMP), an invadopodia-enriched 
matrix metalloproteinase that is responsible for the ECM 
degradation activity of invadopodia [10]. Although further 
studies are needed to elucidate the precise functions of 
caveolin-1 in invadopodia formation, these findings imply 
that  caveolin-1  plays  multiple  roles  in  the  trafficking 
of invadopodia components. Clinical studies showed 
that the increased expression of caveolin-1 is correlated 
with the presence of metastasis and poor prognosis in 
several human cancers [28, 29]. Taken together, blocking 
the functions of lipid rafts and caveolin-1 should be an 
approach to targeting invadopodia-mediated cancer cell 
invasion.
phosphoInosItIde sIgnALIng In 
InvAdopodIA formAtIon
Phosphoinositides are membrane lipids that play 
multiple important roles in diverse cellular functions, 
such  as  membrane  trafficking,  signal  transduction, 
cytoskeletal remodeling and deformation of the plasma 
membrane [30, 31]. Phosphoinositides are reversibly 
phosphorylated at the 3 different positions of the 
inositol headgroup. This generates 7 different species 
of phosphoinositide, namely, phosphatidylinositol 
3-phosphate (PI3P), phosphatidylinositol 4-phosphate 
(PI4P), phosphatidylinositol 5-phosphate (PI5P), 
phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2], 
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], 
phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2], and 
phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P2]. 
There are a large number of enzymes that phosphorylate, 
dephosphorylate, or hydrolyze phosphoinositides to 
locally and temporarily regulate the levels of these 
phosphoinositide species [32-34]. As a result, each 
phosphoinositide has unique cellular distributions, which 
allows them to selectively recruit or activate target proteins 
that have specific phosphoinositide-binding domains [35]. 
PI(4,5)P2 also acts as a precursor of second messengers: 
phospholipase C (PLC) hydrolyzes PI(4,5)P2 to generate 
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate 
(IP3) and phosphoinositide 3-kinase (PI3-kinase) 
phosphorylates PI(4,5)P2 to generate PI(3,4,5)P3 [30, 
36]. Proteins that sever or depolymerize actin filaments 
in vitro,  which  include  gelsolin,  villin,  cofilin,  and 
profilin,  are  inactivated  by  PI(4,5)P2  localized  at  the 
plasma membrane [37]. Conversely, proteins including 
vinculin, talin, ezrin/radixin/moesin (ERM) proteins, 
Wiskott-Aldrich syndrome protein (WASP)/N-WASP, and 
α-actinin, which link actin filaments to each other or to 
the plasma membrane, are activated by this lipid [37, 38]. 
We recently reported that PI(4,5)P2 is enriched 
at invadopodia and blockage of the PI(4,5)P2 function 
suppresses invadopodia formation and ECM degradation 
by invasive human breast cancer cells [39]. We also found 
that a kinase generating PI(4,5)P2, phosphatidylinositol-
4-phosphate 5-kinase type Iα (PIPK Iα), accumulates at 
the invadopodia and that a knockdown of PIPK Iα inhibits 
invadopodia formation. Importantly, the knockdown of 
PIPK Iα only affects a pool of PI(4,5)P2, which is locally 
and newly produced by PIPK Iα. The knockdown of PIPK 
Iα resulted in only a slight decrease in the total amount 
of PI(4,5)P2, and did not affect the PI3-kinase signaling 
pathway, in which PI(4,5)P2 acts as a major substrate. 
Therefore, PI(4,5)P2 seems to exert its function via direct 
regulation of its own targets. Our previous study showed 
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figure 2: A model for the regulation of invadopodia/
podosome formation by membrane lipids.  Lipid 
rafts may act as platforms for the recruitment of components 
of invadopodia/podosomes and for localized signaling by 
phosphoinositides. Caveolin-1 enriched in lipid rafts plays a 
role in cholesterol transport to maintain the levels of plasma 
membrane cholesterol (Chol) and also in MT1-MMP transport 
for the maturation of invadopodia. PI(4,5)P2 generated by PIP 
kinase type Iα (PIPK) acts as a signaling molecule to locally 
activate several invadopodia components, including N-WASP, 
and also serves as a substrate of PI3-kinase (PI3K) for generation 
of PI(3,4,5)P3, which in turn regulates invadopodia formation, 
most likely through PDK1 and Akt. Nck is required for N-WASP 
dependent actin polymerization induced by PI(4,5)P2 and also 
stimulates PIPK for local enrichment of PI(4,5)P2. PI(3,4)P2, 
produced from PI(3,4,5)P3 by the action of a specific phosphatase, 
possibly synaptojanin-2 (SJ-2), recruits Tks5/FISH to the plasma 
membrane, along with its binding partner N-WASP and other 
proteins involved in the formation of invadopodia/podosomes. 
It should be noted that the functions and requirements of these 
molecules may be slightly different between invadopodia and 
podosomes, as well as among cell types.Oncotarget 2010; 1:  320 - 328 323 www.impactjournals.com/oncotarget
that N-WASP and its activators, including Nck, are critical 
regulators of actin polymerization at the invadopodia 
core structures [9]. Because the activation of N-WASP 
is regulated by the amount of PI(4,5)P2 on the plasma 
membrane [40], N-WASP is the most probable candidate 
for the PI(4,5)P2  target.  A  recent  study  identified  the 
existence of the reciprocal interdependence between Nck 
and PI(4,5)P2 for regulation of N-WASP activity [41]. Nck 
is required for N-WASP-dependent actin polymerization 
induced by PI(4,5)P2 and Nck also stimulates PI(4,5)P2 
production via recruitment of PIPK Iα. Considering that 
Nck and PI(4,5)P2 are essential for invadopodia formation 
[9, 39], these components may interdependently 
activate N-WASP to assemble invadopodia structures. 
Other  invadopodia  components,  such  as  cofilin  and 
dynamin-2, are also regulated by PI(4,5)P2 [31]. Arf6 is 
known to activate PIPK Iα for PI(4,5)P2 production [42]. 
Interestingly, synaptojanin-2, a PI(4,5)P2/PI(3,4,5)P3 
phosphatase, is accumulated at invadopodia and required 
for invadopodia formation, which implies that this 
enzyme regulates the turnover of PI(4,5)P2 at invadopodia 
[43]. Taken together, local PI(4,5)P2 metabolism occurs 
at invadopodia and this seems to be a critical event to 
coordinate localization and activation of the invadopodia 
components. Classic biochemical studies have shown that 
phosphoinositide metabolism preferentially occurs within 
lipid raft fractions [44, 45]. Additionally, it has been shown 
that PI(4,5)P2-dependent actin polymerization induced by 
N-WASP and Arp2/3 complex is initiated at the surface 
of the lipid raft-enriched membranes [46, 47]. Therefore, 
lipid rafts and phosphoinositides may cooperatively 
regulate invadopodia formation.
The PI3-kinases are a family of lipid kinases that 
phosphorylate phosphoinositides at the D-3 position of the 
inositol headgroup and thus produce D-3 phosphoinositides 
[48]. PI3-kinases mediate the signal transduction of 
extracellular stimuli and regulate diverse cellular events, 
such as mitogenesis, survival, membrane transport, and cell 
migration [36]. PI3-kinases are subdivided into 3 classes 
(I–III) in mammals on the basis of their enzyme domain 
structures  and  substrate  specificity  [33].  Uncontrolled 
activation of the PI3-kinase signaling pathway leads to 
several pathological phenomena, including tumorigenesis 
and tumor malignancies [36]. This is evidenced by the fact 
that the expression and activity of several members of the 
PI3-kinase signaling pathway are frequently altered in a 
variety of human cancers [49]. PI3-kinase activity is also 
required for invadopodia formation, as shown in invasive 
melanoma cells [50]. In line with this, we recently found 
that class IA PI3K catalytic subunit p110α is selectively 
involved in invadopodia formation in breast cancer cells, 
and that PDK1 and Akt mediate the signaling (manuscript 
in submission). The PIK3CA gene, which encodes p110α, 
is one of the most frequently amplified and mutated genes 
identified  in  human  cancers  [49,  51].  Several  clinical 
studies revealed that mutations leading to the activation 
of the PIK3CA gene are associated with invasive and 
metastatic phenotypes, as well as poor prognosis [52-
54]. Moreover, introduction of the mutant PIK3CA gene 
was reported to enhance the migration, invasion, and 
metastasis of breast cancer cells [55]. Therefore, p110α 
is considered as a promising molecular target for the 
intervention of malignant cancers, and it has led to the 
development of several specific inhibitors [56].
ceLLs of monocyte orIgIn 
generAte podosomes, whIch 
contrIbute to cAncer ceLL 
InvAsIon And osteoLytIc bone 
metAstAsIs
Podosomes are F-actin-rich, dynamic adhesion 
structures found in Src-transformed cells (Fig. 1C) and 
the physiological context of monocyte-derived cells such 
as macrophages and osteoclasts (Fig. 1D). In the past 
decade, the generation of podosomes has been proven 
to be associated with the gene responsible for an X 
chromosome-linked immunodeficiency disease, Wiskott-
Aldrich syndrome (WAS). As macrophages from patients 
with WAS have defects in generating podosomes and 
polarization of the cell [57], these structures are thought 
to be important for chemotactic migration and/or the 
invasion of macrophages. Actually, the product of the 
gene (i.e., WASP) and its ectopic analogue, N-WASP, 
were shown to be indispensable for actin polymerization 
at podosomes via activating the Arp2/3 complex [57–61]. 
It is well established that the neoplastic properties 
of cancer cells are affected by interactions with the tumor 
microenvironment [62]. Tumor-associated macrophages 
(TAMs) have been implicated in tumor progression, 
metastasis, and poor prognosis in several human cancers 
[63, 64]. A paracrine loop between macrophages and cancer 
cells has been proven to facilitate cancer cell migration 
and invasion both in vitro and in vivo,  confirming  the 
vicious role of TAMs [65, 66]. Cancer cells stimulate the 
invasion of macrophages by secreting colony stimulating 
factor-1 (CSF-1), which in turn causes the macrophages 
to stimulate invasion of the cancer cells by secreting 
epidermal growth factor (EGF). EGF and CSF-1 are 
shown to stimulate invadopodia formation in cancer cells 
and podosome formation in macrophages, respectively [6, 
9]. Therefore, the paracrine loop between cancer cells and 
TAMs may promote cancer progression [63, 64] partly via 
the formation of invadopodia/podosomes.
Osteoclasts are highly specialized multi-nucleated 
cells that are differentiated from the monocyte/
macrophage precursors on the bone surface in response 
to  CSF-1  and  receptor  activator  of  nuclear-factor-κB 
ligand (RANKL). During the differentiation into mature 
cells, osteoclasts reorganize the actin cytoskeleton to form 
a dense circumferential band of F-actin (Fig. 1D). This Oncotarget 2010; 1:  320 - 328 324 www.impactjournals.com/oncotarget
ring forms a tight adhesive contact (the sealing zone) that 
defines a subcellular environment (which is known as a 
resorption pit or lacuna) into which H+ and lytic enzymes 
are secreted, thereby allowing effective erosion of the 
bone [58, 67]. The fully mature osteoclast can detach from 
the bone and move away from the resorption lacuna to 
participate in several rounds of resorption, which require 
podosome-associated cell motility [67, 68]. One of the 
upstream regulators of WASP, the cytoplasmic kinase 
Src is essential for osteoclast activity in vivo, because Src 
knockout mice suffer from severe osteopetrosis caused by 
deficient osteoclast activity [69]. Osteoclasts derived from 
such mice cannot adhere and spread properly, and fail to 
give rise to mature sealing zones when attached to the bone. 
Bone metastases from breast cancer are typically osteolytic 
and cause destruction of the bone [70]. Breast cancer cells 
augment the activity of bone resorption via promoting the 
differentiation and podosome formation of osteoclasts 
by  secreting  transforming  growth  factor-beta  (TGF-β), 
tumor necrosis factor-alpha (TNF-α), interleukins (ILs), 
and parathyroid hormone-related protein (PTHrP), which 
leads to osteolytic bone metastasis.
products of pI3-kInAse reguLAte 
podosome formAtIon
PI(3,4,5)P3, which is present in negligible amounts 
under resting conditions, is produced in the plasma 
membrane in response to extracellular stimuli; it is 
synthesized from PI(4,5)P2 by the action of class I PI3-
kinase [36]. PI(3,4)P2 is produced by the action of class I 
and II PI3-kinase on PI(4)P or via the dephosphorylation of 
PI(3,4,5)P3 by PI(3,4,5)P3 5-phosphatases such as SHIP2 
and synaptojanin-2 [31]. These locally produced PI(3,4,5)
P3 and PI(3,4)P2 recruit cytosolic proteins to the plasma 
membrane [35]. For example, the adhesion-mediated 
production of PI(3,4,5)P3 stimulates protein complex 
formation, including PI3-kinase, Src, and gelsolin, which 
is mediated by direct interactions between PI(3,4,5)P3 and 
the Src-homology 2 (SH2) domains of PI3-kinase and/
or Src [71]. Furthermore, phosphoinositides are able to 
modulate the functions of small GTPases of the Arf and 
Rho families, such as Rho, Rac, and Cdc42; these proteins 
are shown to be involved in podosome formation [72-
74]. This modulation occurs via the action of guanine 
nucleotide exchange factors (GEFs) or GTPase-activating 
proteins (GAPs) such as Tiam1, Vav1, and ASAP1 on these 
proteins; all these factors possess pleckstrin homology 
(PH) domains via which they interact with PI(4,5)P2 and/
or PI(3,4,5)P3 [75, 76].
We investigated the localization of different species 
of phosphoinositides using various phosphoinositide-
binding PH domains [77]. We demonstrated that PI(3,4)
P2 is highly enriched in podosomes compared to the 
relatively diffused localization of PI(3,4,5)P3, which is 
also found in lamellipodia and intracellular vesicles. What 
is intriguing is that excessive expression of the PH domain 
of Tapp1, which binds to PI(3,4)P2, as well as the PH 
domain of Akt, which binds both to PI(3,4)P2 and PI(3,4,5)
P3,  significantly  suppressed  podosome  formation.  This 
effect is thought to occur through sequestering those lipids 
by the domains, because the amount of protein expressed 
in a cell tends to correlate with the suppression effect. 
Furthermore, we found that PI(3,4)P2 is synthesized 
by PI3-kinase and synaptojanin-2 in the vicinity of the 
focal adhesions, and that this phosphoinositide triggers 
the recruitment of a protein complex that includes Tks5, 
Grb2, and N-WASP, which results in the conversion of 
the adhesion sites to podosomes [77, 78]. Our results 
support the essential role of synaptojanin-2 in glioma cell 
migration and invasion [43], although the localization of 
PI(3,4)P2 in glioma cells has not been determined. Tks5 
is an adaptor protein with an N-terminal phox homology 
(PX) domain, which was originally identified as an Src 
substrate [79]. Both Tks5 and its relative, Tks4, have been 
shown to play important roles in podosome formation, 
matrix degradation, and tumor growth in vivo [80–83]. 
Recently, they have been shown to mediate the generation 
of reactive oxygen species (ROS) at the invadopodia of 
cancer cells, which is required for invadopodia formation 
and cancer cell invasion [84, 85]. Moreover, Tks5 binds to 
supervillin, a lipid raft-enriched protein which is involved 
in integrin recycling, cell motility, and invadopodia 
formation [86-88], which suggests that they play roles as 
versatile regulators of invadopodia/podosomes. As the PX 
domain of Tks5 binds to PI(3,4)P2, and this interaction is 
essential for podosome formation downstream of Src [77, 
82, 83], targeting this interaction would be a promising 
therapeutic strategy for the selective intervention of 
cancer cell invasion and metastasis. 
concLudIng remArks
As described above, accumulating evidence leaves 
us in no doubt that invadopodia/podosomes play a 
pivotal role in the invasion and metastasis of cancer cells. 
Moreover, podosomes formed by TAMs and osteoclasts 
in the tumor microenvironment seem to play supportive 
roles for cancer invasion and metastasis. The organization 
and components of the plasma membrane, such as lipid 
rafts and phosphoinositides, regulate the formation 
of invadopodia/podosomes. Therefore, targeting the 
molecular components of these structures, which include 
membrane lipids and their synthetic pathways, will 
contribute to the development of new strategies for the 
treatment of cancer invasion and metastasis. 
One question that still remains answered is how lipid 
raft formation/degradation and phosphoinositide turnover 
are spatiotemporally regulated at invadopodia/podosomes. 
It is evident that invadopodia/podosomes are formed 
through several functional steps. Therefore, lipid rafts 
and phosphoinositide species may have distinct functions Oncotarget 2010; 1:  320 - 328 325 www.impactjournals.com/oncotarget
at different stages of invadopodia/podosome formation. 
Furthermore, although invadopodia and podosomes seem 
to share basic molecular components and functions, i.e., 
ECM degradation, their morphologies are quite different, 
even among cell types. If membrane lipids determine the 
site of invadopodia/podosome assembly, they may be 
critical determinants for the morphology, and most likely 
the function, of these structures. Further studies will be 
needed to address these questions.
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